Article
Advances in understanding the pathogenesis of graft‐versus‐host disease
27 Mar 2016
Abstract excerpt
Allogeneic haematopoietic stem cell transplantation (HCT) is a potent immunotherapy with curative potential for several haematological disorders. Overcoming the immunological barrier of acute graft-versus-host disease (GVHD) remains a fundamental impediment to expanding the efficacy of HCT. GVHD reflects a complex pathological interaction between the innate and adaptive immune systems of the host and donor. Over...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
